Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9987500
Human antibodies to PD-1
granted -
US 9982013
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 9968653
Angiopoietin-based interventions for treating cerebral malaria
granted -
US 9968674
Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody
granted -
US 9950076
Maytansinoid derivatives, conjugates thereof, and methods of use
granted -
US 9951127
Anti-ANGPTL3 antibodies and uses thereof
granted -
US 9951141
Antibody-drug conjugates, their preparation and their therapeutic use
granted -
US 9951132
Anti-prokineticin receptor (PROKR) antibodies and uses thereof
granted -
US 9943594
Methods for the treatment of rheumatoid arthritis
granted -
US 9938345
Human antibodies to PD-L1
granted -
US 9938339
Method for treating an eye disease or disorder by administering an antibody that binds angiopoietin-2
granted -
US 9932398
Restricted immunoglobulin heavy chain mice
granted -
US 9926369
Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody
granted -
US 9914763
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 9913461
Genetically modified mouse whose genome comprises a humanized CD274 gene
granted -
US 9901083
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 9901082
Genetically modified non-human animals and methods of use thereof
granted -
US 9890212
Antibodies to human GDF8
granted -
US 9884916
High affinity antibodies to human IL-6 receptor
granted -
US 9840549
Fusion polypeptides capable of activating receptors
granted -
US 9840557
Anti-IL-25 antibodies and uses thereof
granted -
US 9827310
Anti-ErbB3 antibodies and uses thereof
granted -
US 9795121
Humanized C3 animals
granted -
US 9789184
Anti-EGFR antibodies and uses thereof
granted